BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27840921)

  • 1. Recombinant human soluble thrombomodulin protects against brain injury in a CVST rat model, via downregulation of the HMGB1-RAGE axis.
    Gu JJ; Chen JB; Zhang JH; Zhang H; Wang SS
    Mol Med Rep; 2016 Dec; 14(6):5217-5222. PubMed ID: 27840921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HMGB1 and RAGE on brain injury and the protective mechanism of glycyrrhizin in intracranial‑sinus occlusion followed by mechanical thrombectomy recanalization.
    Mu SW; Dang Y; Fan YC; Zhang H; Zhang JH; Wang W; Wang SS; Gu JJ
    Int J Mol Med; 2019 Sep; 44(3):813-822. PubMed ID: 31257456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Treatment with Thrombomodulin Improves Functional Outcomes after Cerebral Ischemia Even if Administration is Delayed.
    Nakano T; Nakamura Y; Matsuyama K; Irie K; Yasumura M; Hirata Y; Yamasaki M; Misumi K; Yamashita Y; Myose T; Matsuo K; Sano K; Kamimura H; Ishikura H; Egawa T; Mishima K
    Thromb Haemost; 2019 Mar; 119(3):467-478. PubMed ID: 30665239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.
    Nakamura Y; Nakano T; Irie K; Sano K; Tanaka J; Yamashita Y; Satho T; Matsuo K; Fujioka M; Ishikura H; Mishima K
    J Neurol Sci; 2016 Mar; 362():278-82. PubMed ID: 26944163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.
    Hirao S; Minakata K; Masumoto H; Yamazaki K; Ikeda T; Minatoya K; Sakata R
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1973-1983.e1. PubMed ID: 28645823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury.
    Gao TL; Yuan XT; Yang D; Dai HL; Wang WJ; Peng X; Shao HJ; Jin ZF; Fu ZJ
    J Trauma Acute Care Surg; 2012 Mar; 72(3):643-9. PubMed ID: 22491548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HMGB1 translocation to neuronal nucleus in rat model with septic brain injury.
    Li Y; Li X; Qu Y; Huang J; Zhu T; Zhao F; Li S; Mu D
    Neurosci Lett; 2017 Apr; 645():90-96. PubMed ID: 27889435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.
    Tanaka J; Seki Y; Ishikura H; Tsubota M; Sekiguchi F; Yamaguchi K; Murai A; Umemura T; Kawabata A
    Br J Pharmacol; 2013 Nov; 170(6):1233-41. PubMed ID: 24004409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
    Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J
    Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
    Wang J; Wang H; Shi J; Ding Y
    Int J Clin Exp Pathol; 2015; 8(10):12028-40. PubMed ID: 26722388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis.
    Tanaka J; Yamaguchi K; Ishikura H; Tsubota M; Sekiguchi F; Seki Y; Tsujiuchi T; Murai A; Umemura T; Kawabata A
    Neuropharmacology; 2014 Apr; 79():112-8. PubMed ID: 24262631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
    Nishida T; Tsubota M; Kawaishi Y; Yamanishi H; Kamitani N; Sekiguchi F; Ishikura H; Liu K; Nishibori M; Kawabata A
    Toxicology; 2016 Jul; 365():48-58. PubMed ID: 27474498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
    Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
    Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.
    Kawabata H; Setoguchi T; Yone K; Souda M; Yoshida H; Kawahara K; Maruyama I; Komiya S
    Spine (Phila Pa 1976); 2010 May; 35(11):1109-15. PubMed ID: 20195207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
    Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
    Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
    Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
    Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients.
    Jhun J; Lee S; Kim H; Her YM; Byun JK; Kim EK; Lee SK; Cho ML; Choi JY
    J Transl Med; 2015 Sep; 13():310. PubMed ID: 26391982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinacanthin-C, A Fat-Soluble Extract from Rhinacanthus nasutus, Modulates High-Mobility Group Box 1-Related Neuro-Inflammation and Subarachnoid Hemorrhage-Induced Brain Apoptosis in a Rat Model.
    Chang CZ; Wu SC; Kwan AL; Lin CL
    World Neurosurg; 2016 Feb; 86():349-60. PubMed ID: 26361320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.